Related Experiment Videos

How effective are cardiopulmonary bypass circuits at removing gaseous microemboli?

Timothy J Jones1, Dwight D Deal, Jason C Vernon

  • 1Department of Anesthesiology, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157-1009, USA.

Insights

Gaseous microemboli (GME) from air in cardiopulmonary bypass (CPB) venous lines can reach the arterial line, potentially causing organ injury. CPB circuit designs vary significantly in their ability to remove these dangerous GME.

Area of Science:

  • Cardiovascular Surgery
  • Biomedical Engineering
  • Medical Device Technology

Background:

  • Intravascular microemboli are linked to organ injury during cardiopulmonary bypass (CPB).
  • Accidental air introduction into the CPB venous line can create gaseous microemboli (GME).

Purpose of the Study:

  • To evaluate the efficacy of different cardiopulmonary bypass (CPB) circuits in removing gaseous microemboli (GME).
  • To assess the progression of GME through CPB circuits from five manufacturers.

Main Methods:

  • An in vitro adult CPB model was utilized.
  • 60 ml of air was introduced into the venous line.
  • GME progression was monitored at five locations within the circuit.

Main Results:

  • Gaseous microemboli (GME) were detected in the arterial line of all tested CPB circuits after air introduction.
  • Significant variation exists among manufacturers regarding GME removal capability.
  • GME passed through all circuit components, including arterial filters, in all tested systems.

Conclusions:

  • Air introduced into the venous line during CPB generates GME that can traverse the entire circuit.
  • CPB circuit design significantly impacts GME filtration efficiency.
  • Prompt management of air in the venous line during CPB is crucial to prevent GME transmission.

Related Concept Videos